Author information from the last article
E-post: michael.bretthauer@medisin.uio.no
Klinisk effektforskning
Universitetet i Oslo
og
Avdeling for transplantasjonsmedisin
Oslo universitetssykehus
Michael Bretthauer er dr.med., spesialist i indremedisin og i fordøyelsessykdommer, professor og overlege.
Articles by Michael Bretthauer
Faecal microbiota transplantation for primary Clostridioides difficile infection
- Sebastian Bø,
- Håvard Wiig,
- Frederik Emil Juul,
- Kjetil K. Garborg,
- Peter Holger Johnsen,
- Michael Bretthauer
19.11.2025:
A woman in her sixties presenting with an acute primary Clostridioides difficile infection declined the recommended antibiotic treatment. She approached our research group directly, requesting a treatment that had demonstrated efficacy in a recently completed randomised trial. The trial was...
Screening for many types of cancer with a single blood sample – too good to be true?
- David Weinberg,
- Michael Bretthauer
22.04.2025:
Better cancer screening is important for public health, but the enthusiasm surrounding multicancer early detection (MCED) tests should be tempered. The prognosis for many cancer patients has improved considerably in the last few years, in part as a result of better prevention and early detection...
Surgical treatment of benign colorectal polyps 2008–21
- Jens Aksel Nilsen,
- Linn Bernklev,
- Michael Bretthauer,
- Mette Kalager,
- Henriette C. Jodal,
- Magnus Løberg,
- Øyvind Holme,
- Frederik Emil Juul,
- Svein Oskar Frigstad
04.09.2024:
Colorectal cancer is the third most common form of cancer globally, and the incidence in Norway is one of the highest in the world (1). Colorectal polyps can potentially develop into colorectal cancer. Until the 1980s, the standard treatment for large colorectal polyps was surgical resection of the...
Sigmoidoscopy and faecal occult blood test – a comparative screening trial
- Thomas de Lange,
- Kristin Ranheim Randel,
- Anna Lisa Schult,
- Markus Dines Knudsen,
- Benedicte Kirkøen,
- Edoardo Botteri,
- Paula Berstad,
- Anita Jørgensen,
- Giske Ursin,
- Michael Bretthauer,
- Geir Hoff
23.05.2017:
Colorectal cancer is a major health issue, both globally and in Norway. Bowel cancer screening is perhaps the most effective method to mitigate the consequences of the disease for patients and society. Large-scale randomised trials show that screening with sigmoidoscopy and faecal occult blood tests...
Incentives and participation in a medical survey
- Dagrun Kyte Gjøstein,
- Anders Huitfeldt,
- Magnus Løberg,
- Hans-Olov Adami,
- Kjetil Garborg,
- Mette Kalager,
- Michael Bretthauer
05.07.2016:
High participation rates in surveys and thus more representative data on health, disease and risk have helped raise the quality of epidemiological research in Norway (1, 2) and the other Scandinavian countries (3) – (5). This has provided us with a unique opportunity to understand disease risks in...
From clinical questions to trustworthy answers
- Per Olav Vandvik,
- Michael Bretthauer,
- Ingrid Charlotte Kongerud
20.08.2013:
Evidence-based practice is based on a combination of the best current research evidence, clinical expertise and the patients’ own preferences. In evidence-based practice, tools are used to find trustworthy answers to relevant clinical questions, and this requires skills in knowledge management. To...